Our free daily oncology focused e-news service.
Subscribe» | Search Archives»
(Sanofi) May 17, 2013 - Sanofi announced today that the pivotal study, JAKARTA, examining the selective JAK2 inhibitor SAR302503 for myelofibrosis (MF), met its primary endpoint in both dose groups.
read corporate press release »
(Wall Street Journal) May 16, 2013 - Doctors are divided about how best to scan "dense" breasts. A look at the options.
read article (paid subscription required) »
(Bloomberg) May 16, 2013 - Should patients undergoing broad DNA testing for a specific ailment be told of unexpected findings that signal risk of cancer or other serious diseases, even if they don't request the information?
read article »
News Story Commentary By Academic and Community Oncologists
Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.
OBR Job Board
Novocure has posted 3 new jobs and Sarah Cannon has 1 job posted on the OBR Job Board.